Teladoc Health (TDOC) EBITDA Margin (2014 - 2026)
Teladoc Health's (TDOC) quarterly EBITDA Margin came in at 6.11% in Q2 2026, up 250.0% year-over-year from 1.75% in Q2 2025, and up 39.27% quarter-over-quarter from 10.06% in Q1 2026.
Analysis
Teladoc Health (TDOC) EBITDA Margin (2014 - 2026) Analysis & Trends
Teladoc Health has disclosed EBITDA Margin across 13 years of filings, most recently posting 6.11% for Q2 2026.
- In Q2 2026, EBITDA Margin rose 250.0% year-over-year to 6.11%; the TTM figure through Jun 2026 stood at 7.5% (up 302.0% YoY), while the FY2025 annual figure was 10.39%, up 2934.0% from the prior year.
- EBITDA Margin came in at 6.11% for Q2 2026 at Teladoc Health, up from 10.06% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 9.64% in Q1 2022 to a low of 598.32% in Q4 2022.
- Average EBITDA Margin over 5 years is 75.42%, with a median of 9.2% recorded in 2023.
- Year-over-year, EBITDA Margin slumped 59085 bps in 2022 and jumped 59301 bps in 2023.
- Over 5 years, EBITDA Margin stood at 598.32% in 2022, then soared by 99 bps to 5.31% in 2023, then sank by 42 bps to 7.53% in 2024, then grew by 26 bps to 5.6% in 2025, then decreased by 9 bps to 6.11% in 2026.
- Per Business Quant data, the three most recent EBITDA Margin figures were 6.11% in Q2 2026, 10.06% in Q1 2026, and 5.6% in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Hinge Health | 7.41 Bn | 7.03 Bn | 183.95 Mn | 19.00% |
| 2 | Hims & Hers Health | 6.47 Bn | 5.63 Bn | 480.80 Mn | -12.90% |
| 3 | Ethos Technologies | 2.54 Bn | 2.37 Bn | 185.54 Mn | 9.56% |
| 4 | Omada Health | 1.38 Bn | 1.16 Bn | 63.79 Mn | 4.04% |
| 5 | Teladoc Health | 1.14 Bn | 366.41 Mn | 416.09 Mn | -6.11% |
| 6 | Talkspace | 870.58 Mn | 779.48 Mn | 24.80 Mn | -3.43% |
| 7 | Akso Health | 259.44 Mn | 259.25 Mn | - | - |
| 8 | LifeMD | 147.29 Mn | 147.29 Mn | - | - |
| 9 | eHealth | 31.71 Mn | -69.34 Mn | - | -81.80% |
| 10 | Mangoceuticals | 7.39 Mn | 7.14 Mn | 44,215.00 | -1,502.45% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6.11% |
| Mar 31, 2026 | -10.06% |
| Dec 31, 2025 | -5.60% |
| Sep 30, 2025 | -8.29% |
| Jun 30, 2025 | -8.61% |
| Mar 31, 2025 | -19.16% |
| Dec 31, 2024 | -7.53% |
| Sep 30, 2024 | -6.93% |
| Jun 30, 2024 | -130.93% |
| Mar 31, 2024 | -13.48% |
| Dec 31, 2023 | -5.31% |
| Sep 30, 2023 | -9.80% |
| Jun 30, 2023 | -10.98% |
| Mar 31, 2023 | 8.39% |
| Dec 31, 2022 | -598.32% |
| Sep 30, 2022 | -11.73% |
| Jun 30, 2022 | -522.73% |
| Mar 31, 2022 | 9.64% |
| Dec 31, 2021 | -7.47% |
| Sep 30, 2021 | -11.61% |